rs2583764

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000880.4(IL7):​c.148-11483T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.283 in 152,070 control chromosomes in the GnomAD database, including 8,261 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 8261 hom., cov: 32)

Consequence

IL7
NM_000880.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.37

Publications

10 publications found
Variant links:
Genes affected
IL7 (HGNC:6023): (interleukin 7) The protein encoded by this gene is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL7 is found to be a cofactor for V(D)J rearrangement of the T cell receptor beta (TCRB) during early T cell development. This cytokine can be produced locally by intestinal epithelial and epithelial goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes. IL7 plays an essential role in lymphoid cell survival, and in the maintenance of naive and memory T cells. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their presence in normal tissues has not been confirmed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be a potent inducer of proinflammatory cytokines and chemokines which may defend against the infection, but may also mediate destructive lung injury. Elevated serum IL7 levels, together with several other circulating cytokines and chemokines, has been found to be associated with the severity of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Jul 2020]
IL7 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • epidermodysplasia verruciformis, susceptibility to, 5
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000880.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL7
NM_000880.4
MANE Select
c.148-11483T>C
intron
N/ANP_000871.1
IL7
NM_001199887.2
c.148-11483T>C
intron
N/ANP_001186816.1
IL7
NM_001199886.2
c.148-11483T>C
intron
N/ANP_001186815.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL7
ENST00000263851.9
TSL:1 MANE Select
c.148-11483T>C
intron
N/AENSP00000263851.4
IL7
ENST00000518982.5
TSL:1
n.148-4469T>C
intron
N/AENSP00000430272.1
IL7
ENST00000520317.1
TSL:1
n.92-11483T>C
intron
N/AENSP00000427800.1

Frequencies

GnomAD3 genomes
AF:
0.283
AC:
43007
AN:
151952
Hom.:
8220
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.543
Gnomad AMI
AF:
0.0910
Gnomad AMR
AF:
0.255
Gnomad ASJ
AF:
0.202
Gnomad EAS
AF:
0.310
Gnomad SAS
AF:
0.154
Gnomad FIN
AF:
0.173
Gnomad MID
AF:
0.209
Gnomad NFE
AF:
0.163
Gnomad OTH
AF:
0.263
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.283
AC:
43110
AN:
152070
Hom.:
8261
Cov.:
32
AF XY:
0.284
AC XY:
21103
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.543
AC:
22528
AN:
41450
American (AMR)
AF:
0.255
AC:
3905
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.202
AC:
701
AN:
3468
East Asian (EAS)
AF:
0.310
AC:
1601
AN:
5162
South Asian (SAS)
AF:
0.153
AC:
736
AN:
4812
European-Finnish (FIN)
AF:
0.173
AC:
1833
AN:
10582
Middle Eastern (MID)
AF:
0.201
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
0.163
AC:
11100
AN:
67982
Other (OTH)
AF:
0.267
AC:
564
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1354
2708
4063
5417
6771
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
396
792
1188
1584
1980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.254
Hom.:
1211
Bravo
AF:
0.304
Asia WGS
AF:
0.279
AC:
971
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.27
DANN
Benign
0.64
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2583764; hg19: chr8-79663800; API